Marsico Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,507
| Closed | -$2.69M | – | 65 |
|
|
2024
Q2 | $2.69M | Hold |
19,507
| – | – | 0.08% | 54 |
|
|
2024
Q1 | $2.69M | Sell |
19,507
-40,816
| -68% | -$5.63M | 0.09% | 58 |
|
|
2023
Q4 | $7.95M | Hold |
60,323
| – | – | 0.31% | 43 |
|
|
2023
Q3 | $6.79M | Sell |
60,323
-8,318
| -12% | -$936K | 0.29% | 44 |
|
|
2023
Q2 | $6.47M | Sell |
68,641
-82,298
| -55% | -$7.76M | 0.26% | 45 |
|
|
2023
Q1 | $15.3M | Sell |
150,939
-1,000
| -0.7% | -$101K | 0.72% | 29 |
|
|
2022
Q4 | $18.1M | Buy |
+151,939
| New | +$18.1M | 0.94% | 26 |
|